# Pyromeconic acid-enriched Erigeron annuus water extract as a cosmetic ingredient for itch relief and anti-inflammatory activity

**Authors:** Minkyoung Kang, Minji Kang, Tae Hee Kim, Seong Un Jeong, Sangnam Oh

PMC · DOI: 10.1038/s41598-024-55365-2 · 2024-02-26

## TL;DR

This study shows that a water extract from Erigeron annuus and its main ingredient, pyromeconic acid, can reduce itching and inflammation, making them promising for cosmetic use.

## Contribution

The study identifies pyromeconic acid-enriched Erigeron annuus extract as a novel functional cosmetic ingredient with anti-inflammatory and anti-itch properties.

## Key findings

- EEA and PA reduced histamine secretion and pro-inflammatory cytokines in human mast cells and keratinocytes.
- EEA and PA enhanced antioxidant enzymes and reduced oxidative stress in HaCaT cells.
- EEA and PA improved skin barrier function and modulated inflammatory gene expression.

## Abstract

Erigeron annuus (EA), traditionally used to treat disorders such as diabetes and enteritis, contains a variety of chemicals, including caffeic acid, flavonoids, and coumarins, providing antifungal and antioxidative benefits. However, the ingredients of each part of the EA vary widely, and there are few reports on the functionality of water extracts in skin inflammation and barrier protection. We assessed the therapeutic properties of the extract of EA without roots (EEA) and its primary ingredient, pyromeconic acid (PA), focusing on their antihistamine, anti-inflammatory, and antioxidative capabilities using HMC-1(human mast cells) and human keratinocytes (HaCaT cells). Our findings revealed that histamine secretion, which is closely related to itching, was notably reduced in HMC-1 cells following pretreatment with EEA (0.1% and 0.2%) and PA (corresponding concentration, 4.7 of 9.4 µg/mL). Similarly, they led to a marked decrease in the levels of pro-inflammatory cytokines, including IL-1β, IL-8, IL-6, and IFN-γ. Furthermore, EA and PA enhanced antioxidant enzymes, such as superoxide dismutase (SOD) and catalase (CAT), reduced malondialdehyde (MDA) production, and showed reactive oxygen species (ROS) scavenging activity in HaCaT cells. Moreover, at the molecular level, elevated levels of the pro-inflammatory cytokines IL-1β, IL-6, TARC, and MDC induced by TNF-α/IFN-γ in HaCaT cells were mitigated by treatment with EEA and PA. We also revealed the protective effects of EEA and PA against SDS-induced skin barrier dysfunction in HaCaT cells by enhancing the expression of barrier-related proteins. Using NanoString technology, a comprehensive analysis of gene expression changes indicated significant modulation of autoimmune and inflammatory genes by EEA and PA. In summary, this study suggests that EEA and the corresponding concentration of PA as an active ingredient have functional cosmetic applications to alleviate itching and improve skin health.

## Linked entities

- **Proteins:** SOD1 (superoxide dismutase 1), CAT (catalase), so (sine oculis), ROS1 (ROS proto-oncogene 1, receptor tyrosine kinase), IL1B (interleukin 1 beta), CXCL8 (C-X-C motif chemokine ligand 8), IL6 (interleukin 6), IFNG (interferon gamma), CCL17 (C-C motif chemokine ligand 17), ADAM11 (ADAM metallopeptidase domain 11)
- **Chemicals:** pyromeconic acid (PubChem CID 68129), caffeic acid (PubChem CID 689043), coumarins (PubChem CID 54678486), malondialdehyde (PubChem CID 10964)
- **Diseases:** diabetes (MONDO:0005015), enteritis (MONDO:0043579), skin inflammation (MONDO:0002406)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** CCL17 (C-C motif chemokine ligand 17) [NCBI Gene 6361] {aka A-152E5.3, ABCD-2, SCYA17, TARC}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CAT (catalase) [NCBI Gene 847], SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}
- **Diseases:** itch (MESH:D011537), diabetes (MESH:D003920), inflammatory (MESH:D007249), barrier dysfunction (MESH:C536830), enteritis (MESH:D004751)
- **Chemicals:** water (MESH:D014867), EA without roots (-), histamine (MESH:D006632), SDS (MESH:D012967), coumarins (MESH:D003374), caffeic acid (MESH:C040048), ROS (MESH:D017382), flavonoids (MESH:D005419), PA (MESH:C030415), MDA (MESH:D008315)
- **Species:** Enterovirus A (no rank) [taxon 138948], Homo sapiens (human, species) [taxon 9606], Erigeron annuus (eastern daisy fleabane, species) [taxon 91248]
- **Cell lines:** HaCaT — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0038), HMC-1 — Homo sapiens (Human), Mast cell leukemia, Cancer cell line (CVCL_0003)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10897215/full.md

---
Source: https://tomesphere.com/paper/PMC10897215